(Q34432193)

2 August 2017

title

Looking into anti-angiogenic gene therapies for disorders of the eye. (English)

1 reference

2 August 2017

main subject

angiogenesis inhibitor

1 reference

Henrik S. Rasmussen

1

1 reference

2 August 2017

Camilla S. Rasmussen

2

1 reference

2 August 2017

Rebecca G. Durham

3

1 reference

2 August 2017

C Richter King

4

1 reference

2 August 2017

Lisa Wei

5

1 reference

2 August 2017

publication date

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

6

1 reference

2 August 2017

issue

22

1 reference

2 August 2017

page(s)

1171-1175

1 reference

Treatment of diabetic retinopathy

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Diabetic Retinopathy: A Further Study of Prognosis for Vision

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

How effective are treatments for diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Angiogenesis and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Ocular gene therapy: experimental studies and clinical possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Gene therapy for ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Unraveling immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

PEDF: Raising both hopes and questions in controlling angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902034-7

7 January 2021

10.1016/S1359-6446(01)02034-7

Identifiers

DOI

1 reference

2 August 2017

1 reference